Comparative study of antiulcer activity of dry aspen bark extracts in different dosage forms

Written by Krylova S.G., Turetskova V.F., Makarova О.G., Efimova L.А., Zueva Е.P., Rybalkina О.Y.

  UDK: 615.243/.32.014.21 | Pages: 18-21 | Full text PDF | Open PDF 


Background. One of the essential medical tasks is an efficient choice of dosage forms according to main points of biopharmaceutical concepts. An advantageous object for such development is a dry as-pen bark extract (“Ekorsin”), created by joint collaboration of Pharmaceutical technology department, ASMU, RIPRM named E.D. Goldberg and CJSC “Altaivitaminy”. Its pilled dosage form showed high antiulcer activity at preclinical stage which was confirmed at clinical stage. Methods. For a comparative study of the pharmacological activity of the tablets “Ekorsin” and newly developed dosage form - capsules “Ekorsin forte”- conventional models of neurogenic and indometacin ulcerogenesis were used in two animal species. Results. In the context of the model of neurogenic ulcer formation in mice revealed preferential antiul-cer efficacy of capsule with a mixture of dry aspen bark extract. In the context of indometacin defect of gastric mucosa in mice revealed prominent antiulcer efficacy of a capsule mixture which were more active than pills. Conclusions. Benchmark assessment of antiulcer activity in two models of experimental ulcerogenesis in mice and rats suggests surpassing activity of the capsules “Ekorsin forte” to pills “Ekorsin”. Activity varied depending on genesis of ulcerous destruction.

Links to authors:

S.G. Krylova1, V.F. Turetskova2, О.G. Makarova2, L.А. Efimova1, Е.P. Zueva1, 3, О.Y. Rybalkina1, 3
1 Rech Institute of Pharmacology and Regenerative Medicine named E.D. Goldberg (3 Lenina Ave. Tomsk 634028 Russian Federation),
2 Altaic State Medical University (40 Lenina Ave. Barnaul 656038 Russian Federation)

1. Demina N.B. Biopharmacy is a way for the creation of innovative medicines // Development and registration of medicinal products. 2013. No.1 (2). P. 8–14.
2. Zueva E.P., Reykhart D.V., Krylova S.G. [et al.] Medicinal plants in the treatment of gastric ulcer and duodenal ulcer. Tomsk: Tomsk University Press, 2003. 212 p.
3. Lakin G.F. Biometry. М.: Higher School, 1990. 352 p.
4. Mashkovskiy M.D. Medicinal Products. М.: New Wave, 2002. Vol.1. 540 p.; Vol. 2. 608 p.
5. Guidelines for preclinical studies of medecines / edited by А.N. Mironov [et al.] Part I. М.: Grif and Co, 2013. 944 p.
6. Tentsova A.I., Azhgikhin I.S. The dosage form and therapeutic efficacy of medicines. М: Medicine, 1974. 335 p.
7. Turetskova V.F., Makarova O.G., Krylova S.G. Gastroretentive tablets and capsules with aspen dry bark extract. Palmarium Academic Publishing House (Germany), 2014. 128 p.
8. Krylova S.G., Zueva E.P., Razina T.G. [et al.] The dry extract of the aspen bark in the experimental therapy of gastric ulcer // Experimental and Clinical Pharmacology, 2000. Vol. 63, No. 2. P. 44–47.
9. Krylova S.G., Zueva E.P., Razina T.G. [et al.] Influence of dry extract of the aspen bark on the secretory function of the stomach // Experimental and Clinical Pharmacology, 2000. Vol. 63, No. 5. P. 31–33.
10. Khoyman D., Gromova L.I., Sela Y. Gastroretentive dosage forms with controlled release // Pharmaceutical Chemistry Journal, 2004. Vol. 38, No. 11. P. 94–97.
11. Deshpande A.A. Controlled-released drug delivery system for prolonged gastric residence // Pharmaceutical Research. 1997. No. 14 (6). P. 815–822.
12. European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Strasburg: Council of Europe, 1986. 51 p.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.